カテゴリー:
[Webinar] SDGs Specialist: Masaki Inaba Announcement of the 1st Special Lecture Series
SDGs Promise Japan announces that a special seminar will be held. From 15:00 to 17:00 on January 14,READ MORE
[News] Eliminating onchocerciasis and lymphatic filariasis: Reaching the last mile
A report " Eliminating onchocerciasis and lymphatic filariasis: Reaching the last mile " on onchocerREAD MORE
The final draft of the Kigali Declaration has been released
Today, the final draft of the Neglected Tropical Diseases (NTDs) Kigali Declaration has been publishREAD MORE
[Paper introduction] Potential of China's Development Assistance for Health on Neglected Tropical Diseases
Introducing the paper " Potential of China's Development Assistance for Health on Neglected TropicalREAD MORE
カテゴリー:
[Webinar] Completion of Phase III study of schistosomiasis pediatric drug "Arapraziquantel" -Toward a new treatment option for preschool children suffering from schistosomiasis-
Announcing a special webinar by the Praziquantel Consortium for Children and the GHIT Fund . Click hREAD MORE
[Paper introduction] Diagnostics to support elimination of lymphatic filariasis—Development of two target product profiles
Introducing the paper "Diagnostics to support elimination of lymphatic filariasis—Development of twoREAD MORE
[Webinar] Notice of Completion of the Pediatric Praziquantel Consortium's pivotal Phase III trial
Webinar announcement from Pediatric Praziquantel Consortium . Completion of the Pediatric PraziquantREAD MORE
カテゴリー:
[News] ADP Status Report 2021 has been released
Access and Delivery Partnership (ADP) Status Report 2021 is now available. Click here to download ThREAD MORE
カテゴリー:
[Webinar] Information on DNDi Japan Scientific Seminar 2021
DNDi (Drugs for Neglected Diseases initiative) announces a zoom webinar. DNDi Japan Scientific SeminREAD MORE
カテゴリー:
[News] Phase III study of schistosomiasis pediatric formulation "Arapraziquantel" by the pediatric Praziquantel Consortium has been completed. Good results are obtained in terms of efficacy and safety.
Introducing the press release of the Global Health Innovative Technology Fund (GHIT Fund). Click herREAD MORE
